Stock listing
JUNS Stock Price, News, Filings & Events — Jupiter Neurosciences, Inc.
Selected listing: JUNS · NASDAQ · USD · US
This page tracks Jupiter Neurosciences, Inc.'s JUNS:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following JUNS:NASDAQ. JUNS:NASDAQ is the stock-level entry point for investors researching Jupiter Neurosciences, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Jupiter Neurosciences, Inc. (ticker: JUNS) is a public company based in the United States, with a market capitalization of approximately $8.3 million. The company focuses on developing innovative solutions in the field of neuroscience. Investors can track its performance and updates on the stock market.
- Ticker
- JUNS:NASDAQ
- Asset type
- Stock
- Market cap
- $4.0M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
Jupiter Neurosciences, Inc. JUNS:NASDAQ stock context
This page tracks Jupiter Neurosciences, Inc.'s JUNS:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following JUNS:NASDAQ. JUNS:NASDAQ is the stock-level entry point for investors researching Jupiter Neurosciences, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Jupiter Neurosciences, Inc. (ticker: JUNS) is a public company based in the United States, with a market capitalization of approximately $8.3 million. The company focuses on developing innovative solutions in the field of neuroscience. Investors can track its performance and updates on the stock market.
Latest news from Jupiter Neurosciences, Inc.
Jupiter Neurosciences, Inc. Announces Reverse Stock Split
August 5, 2026
Jupiter Neurosciences Signs Definitive Agreement for Exclusive U.S. Rights to ALA-002 in Transaction Valued at Up to $100 Million
July 22, 2026
Jupiter Neurosciences (NASDAQ: JUNS) Signs Definitive Agreement for Exclusive U.S. Rights to ALA-002 in Transaction Valued at Up to $100 ...
July 21, 2026
Jupiter Neurosciences Strengthens Board with Appointment of Dr. Tomas J. Philipson
July 7, 2026
Jupiter Neurosciences Announces Patient Enrollment Underway in Phase 2a RESET Trial in Parkinson’s Disease
May 27, 2026
Research Jupiter Neurosciences, Inc.
Jupiter Neurosciences, Inc. investor report
Review AI stock analysis and investor report context for JUNS:NASDAQ.
Jupiter Neurosciences, Inc. company profile
View the public company page for Jupiter Neurosciences, Inc. on 6ix.
Jupiter Neurosciences, Inc. news
Read company news and market updates connected to Jupiter Neurosciences, Inc..
Jupiter Neurosciences, Inc. investor events
Find investor webinars, events, and replay context for Jupiter Neurosciences, Inc..